ArticleFrontiers in immunology2022

Low dose versus standard dose rituximab for the treatment of antiphospholipid syndrome: A pilot study from a tertiary medical center.

Yuzhou Gan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.